Jaanh Cosmetics,Inc.
Financials
Valuation Metrics
Jaanh Cosmetics,Inc.'s Market Cap is ₩558B. At end of 2025 it was ₩339B. Ranked #1662 of 2,436 in KR market (top 68%), #991 of 1,649 on KOSDAQ (top 60%), #34 of 47 in Consumer Discretionary Distribution & Retail (top 72%) by Market Cap.
Investment Metrics(as of 2026-08-04)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 55.77B KRW | KR#1,662/2,436 Sec#34/47 |
| Revenue | 51.56B KRW | KR#1,754/2,436 Sec#34/47 |
| Net Income | -7.32B KRW | KR—/2,436 Sec—/47 |
| Total Assets | 37.10B KRW | KR#2,289/2,436 Sec#42/47 |
| Net Assets | 17.59B KRW | KR#2,307/2,436 Sec#43/47 |
| Employees | 79 | KR#1,799/2,436 Sec#31/47 |
| Value | ||
| P/B | 3.17x | KR#2,133/2,436 Sec#42/47 |
| P/S | 1.08x | KR#1,452/2,436 Sec#34/47 |
| EV/EBITDA | 54.41x | KR#1,362/2,436 Sec#29/47 |
| FCF Yield | -10.08% | KR—/2,436 Sec—/47 |
| Profitability | ||
| ROE | -41.62% | KR#2,239/2,436 Sec#42/47 |
| ROA | -19.74% | KR#2,229/2,436 Sec#40/47 |
| Op. Margin | 2.21% | KR#1,331/2,436 Sec#25/47 |
| Revenue Growth | 74.84% | KR#186/2,436 Sec#7/47 |
| Financial Health | ||
| Debt Ratio | 110.88% | KR#462/2,436 Sec#5/47 |
| Total Debt | 8.98B KRW | KR#1,657/2,436 Sec#35/47 |
| FCF | -5.62B KRW | KR#1,528/2,436 Sec#29/47 |
| Cash | 2.66B KRW | KR#2,185/2,436 Sec#40/47 |
| Current Ratio | 1.30x | KR#1,469/2,436 Sec#25/47 |
| Net Debt/EBITDA | 5.54x | KR#1,116/2,436 Sec#20/47 |
| Performance | ||
| 1Y Return | -31.98% | KR#1,614/2,436 Sec#26/47 |
| 1M Return | 34.89% | KR#51/2,436 Sec#3/47 |
| From 52W High | -38.64% | KR#698/2,436 Sec#18/47 |
| 1Y MDD | -73.75% | KR#2,092/2,436 Sec#38/47 |
| Trading | ||
| Volume | 59,680 shares | KR#1,239/2,436 Sec#21/47 |
| Foreign Own. | 6.16% | KR#699/2,436 Sec#17/47 |
| Per Share | ||
| EPS | -227 KRW | KR—/2,436 Sec—/47 |
| BPS | 459 KRW | KR#2,395/2,436 Sec#47/47 |
Company Info
Established in 2000, DYD operates in the cosmetics and bio industries, having been listed on the KOSDAQ market in 2015. The company sells its own brands, including the sensuously designed 'lilybyred', basic cosmetics 'Hathorinn', and vegan brand 'Slow Huming', through online, offline, and overseas master distributors. In its bio business, DYD combines semiconductor surface technology with antibody conjugation technology to develop a diabetes diagnostic kit for rapid glycated albumin measurement, leading healthcare innovation based on advanced biotechnology. DYD is headquartered in Goyang-si, Gyeonggi-do.